Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Diltiazem · Cardizem Cd, Diltiazem Hydrochloride

Small molecule · Inhibitor of L-type calcium channel · developed by Bausch

Approved FDA, Nov 1982
1 Registered trials

What is Diltiazem?

Diltiazem is a non-dihydropyridine calcium-channel blocker that inhibits calcium ion influx during membrane depolarization in cardiac and vascular smooth muscle. It slows atrioventricular nodal conduction and reduces peripheral vascular resistance. It is used in cardiovascular conditions including supraventricular arrhythmias, atrial fibrillation or flutter, angina and hypertension.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Cardizem Cd, Diltiazem Hydrochloride, Diltiazem Hydrochloride In Sodium Chloride
Drug type
Small molecule
Targets
L-type calcium channel
Mechanism
Inhibitor of L-type calcium channel
Pathways
calcium influx inhibition during membrane depolarization, AV nodal conduction slowing, peripheral vascular smooth muscle relaxation
Therapy area
Cardiovascular
Developer
Bausch
In trials of
VTRS
FDA status
Approved as Cardizem Cd, Diltiazem Hydrochloride, Diltiazem Hydrochloride In Sodium Chloride (November 5, 1982), NDA018602 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Dec 10, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02479204 Phase 1 Healthy Subjects Terminated VTRS

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Healthy Subjects

Sources

Updated Nov 22, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.